TransMedics (TMDX) Receivables (2018 - 2026)

TransMedics' Receivables history runs 9 years deep, the most recent figure standing at $90.7 million for Q1 2026.

• In Q1 2026, Receivables fell 36.12% year-over-year to $90.7 million; the TTM figure through Mar 2026 stood at $90.7 million (down 36.12% YoY), while the FY2025 annual figure was $84.3 million, down 13.75% from the prior year.
• Receivables was $90.7 million for Q1 2026 at TransMedics, up from $84.3 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $142.0 million in Q1 2025 to a low of $11.7 million in Q1 2022.
• Historically, Receivables has averaged $67.1 million across 5 years, with a median of $80.7 million in 2025.
• The sharpest annual moves came in 2022 and 2026: Receivables soared 430.96% in 2022, then slumped 36.12% in 2026.
• A 5-year view of Receivables shows it stood at $27.6 million in 2022, then jumped by 130.26% to $63.6 million in 2023, then soared by 53.71% to $97.7 million in 2024, then dropped by 13.75% to $84.3 million in 2025, then advanced by 7.65% to $90.7 million in 2026.
• The last three Receivables figures came in at $90.7 million (Q1 2026), $84.3 million (Q4 2025), and $80.7 million (Q3 2025), per Business Quant data.